135 related articles for article (PubMed ID: 6392688)
1. [Effect of prostacycline on pulmonary circulation in pulmonary hypertension].
Szczeklik J; Nizankowski R; Ruzyłło W; Bijak A
Kardiol Pol; 1984; 27(7):607-12. PubMed ID: 6392688
[No Abstract] [Full Text] [Related]
2. The acute effects of prostacyclin on pulmonary hemodynamics in patients with pulmonary hypertension secondary to systemic sclerosis.
Menon N; McAlpine L; Peacock AJ; Madhok R
Arthritis Rheum; 1998 Mar; 41(3):466-9. PubMed ID: 9506575
[TBL] [Abstract][Full Text] [Related]
3. [Prostanoids in the treatment of pulmonary arterial hypertension].
Başkurt M; Küçükoğlu MS
Anadolu Kardiyol Derg; 2010 Sep; 10 Suppl 2():2-8. PubMed ID: 20819749
[TBL] [Abstract][Full Text] [Related]
4. [Short- and long-term effects of the new oral prostacyclin analogue, beraprost sodium, in patients with severe pulmonary hypertension].
Saji T; Ozawa Y; Nakayama T; Matsuura H; Hashiguchi R; Matsuo N; Muto H; Yamazaki J; Morishita T; Saito T
J Cardiol; 1996 Apr; 27(4):197-205. PubMed ID: 8642506
[TBL] [Abstract][Full Text] [Related]
5. [Differences in the effect of verapamil on pulmonary circulation in primary pulmonary hypertension].
Dubiel JP; Brzostek T; Zmudka K; Bielecki A
Przegl Lek; 1987; 44(5):421-4. PubMed ID: 3659402
[No Abstract] [Full Text] [Related]
6. Long-term follow-up of portopulmonary hypertension: effect of treatment with epoprostenol.
Fix OK; Bass NM; De Marco T; Merriman RB
Liver Transpl; 2007 Jun; 13(6):875-85. PubMed ID: 17539008
[TBL] [Abstract][Full Text] [Related]
7. Treatment of primary pulmonary hypertension.
Handa S
Intern Med; 2002 Oct; 41(10):757-8. PubMed ID: 12412989
[No Abstract] [Full Text] [Related]
8. [The pulmonary vasodilatory effect of inhaled prostacyclin and milrinone in heart].
Ricksten S
Rev Esp Anestesiol Reanim; 2001 Dec; 48(10):460-1. PubMed ID: 11792300
[TBL] [Abstract][Full Text] [Related]
9. [The behaviour of haemodynamic indicators of pulmonary circulation and spirometric parametera under the influence of Sadamin in patients with chronic pulmonary heart syndrome].
Horzela T; Dubiel JP; Dubiel JS; Szczeklik J; Zbigniew P; Karczmarz A; Mysik M
Przegl Lek; 1975; 32(4):379-83. PubMed ID: 1129511
[No Abstract] [Full Text] [Related]
10. [Primary pulmonary hypertension. Treatment with prostacyclin I2 (epoprostenol)].
Vicente R; Ramos F; Morales P
Rev Esp Anestesiol Reanim; 1999; 46(6):274. PubMed ID: 10439652
[No Abstract] [Full Text] [Related]
11. [Effect of intra-arterial administration of isosorbide dinitrate on various hemodynamic parameters of pulmonary circulation and the right heart in patients with secondary pulmonary hypertension].
Dubiel JP; Kmita A; Brzostek T; Zmudka K
Kardiol Pol; 1986; 29(11-12):724-31. PubMed ID: 3599609
[No Abstract] [Full Text] [Related]
12. [Vasoconstrictor action of ibuprofen in treating patients with pulmonary hypertension].
Gavrisiuk VK; Diachenko AP; Krasnostup NA; Iachnik AI; Draga NP
Vrach Delo; 1989 Jan; (1):62-4. PubMed ID: 2718450
[TBL] [Abstract][Full Text] [Related]
13. Endothelin-1 across the lung circulation in patients with pulmonary arterial hypertension and influence of epoprostenol infusion.
Selimovic N; Andersson B; Bergh CH; Sakiniene E; Carlsten H; Rundqvist B
J Heart Lung Transplant; 2009 Aug; 28(8):808-14. PubMed ID: 19632577
[TBL] [Abstract][Full Text] [Related]
14. Acute and chronic effects of sildenafil in patients with pulmonary arterial hypertension.
Preston IR; Klinger JR; Houtches J; Nelson D; Farber HW; Hill NS
Respir Med; 2005 Dec; 99(12):1501-10. PubMed ID: 15890512
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary hypertension, pulmonary blood vessels and vasoactive drugs.
Wanstall JC
Proc West Pharmacol Soc; 1997; 40():137-40. PubMed ID: 9436235
[TBL] [Abstract][Full Text] [Related]
16. High levels of nitric oxide in individuals with pulmonary hypertension receiving epoprostenol therapy.
Ozkan M; Dweik RA; Laskowski D; Arroliga AC; Erzurum SC
Lung; 2001; 179(4):233-43. PubMed ID: 11891614
[TBL] [Abstract][Full Text] [Related]
17. Combined therapy with inhaled nitric oxide and intravenous epoprostenol (prostacyclin) for critical pulmonary perfusion after the Fontan procedure.
Miyaji K; Nagata N; Miyamoto T; Kitahori K
J Thorac Cardiovasc Surg; 2003 Feb; 125(2):437-9. PubMed ID: 12579126
[No Abstract] [Full Text] [Related]
18. Vasodilator therapy after heart transplantation: effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside.
Kieler-Jensen N; Lundin S; Ricksten SE
J Heart Lung Transplant; 1995; 14(3):436-43. PubMed ID: 7654728
[TBL] [Abstract][Full Text] [Related]
19. Successful transition from intravenous to inhaled prostacyclin in a patient with pulmonary hypertension and right ventricular failure.
Reddy MT; Patel H; Ventura HO
Congest Heart Fail; 2008; 14(5):285-6. PubMed ID: 18983294
[No Abstract] [Full Text] [Related]
20. Treprostinil: new drug. Pulmonary artery hypertension: just another (disappointing) prostacycline analogue.
Prescrire Int; 2006 Oct; 15(85):177-9. PubMed ID: 17128524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
